Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells
Patrick Imesch(University Hospital of Zurich), André Fedier(University of Zurich)
Cited by 46
Related Papers
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
|Oncotarget|2014|145
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
|International Journal of Oncology|2007|37
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells
|International Journal of Oncology|2009|10
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
|International Journal of Oncology|2022|9
Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells
|Experimental and Therapeutic Medicine|2013|8